117 related articles for article (PubMed ID: 34378900)
1. [The role of RIPK4 in epidermis physiology].
Wolnicka-Głubisz A; Madej E; Lisek A
Postepy Biochem; 2021 Mar; 67(1):64-71. PubMed ID: 34378900
[TBL] [Abstract][Full Text] [Related]
2. A novel RIPK4-IRF6 connection is required to prevent epithelial fusions characteristic for popliteal pterygium syndromes.
De Groote P; Tran HT; Fransen M; Tanghe G; Urwyler C; De Craene B; Leurs K; Gilbert B; Van Imschoot G; De Rycke R; Guérin CJ; Holland P; Berx G; Vandenabeele P; Lippens S; Vleminckx K; Declercq W
Cell Death Differ; 2015 Jun; 22(6):1012-24. PubMed ID: 25430793
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel mutation in RIPK4 in a kindred with phenotypic features of Bartsocas-Papas and CHAND syndromes.
Gollasch B; Basmanav FB; Nanda A; Fritz G; Mahmoudi H; Thiele H; Wehner M; Wolf S; Altmüller J; Nürnberg P; Frank J; Betz RC
Am J Med Genet A; 2015 Nov; 167A(11):2555-62. PubMed ID: 26129644
[TBL] [Abstract][Full Text] [Related]
4. Mutations in RIPK4 cause the autosomal-recessive form of popliteal pterygium syndrome.
Kalay E; Sezgin O; Chellappa V; Mutlu M; Morsy H; Kayserili H; Kreiger E; Cansu A; Toraman B; Abdalla EM; Aslan Y; Pillai S; Akarsu NA
Am J Hum Genet; 2012 Jan; 90(1):76-85. PubMed ID: 22197489
[TBL] [Abstract][Full Text] [Related]
5. Confirmation that RIPK4 mutations cause not only Bartsocas-Papas syndrome but also CHAND syndrome.
Busa T; Jeraiby M; Clémenson A; Manouvrier S; Granados V; Philip N; Touraine R
Am J Med Genet A; 2017 Nov; 173(11):3114-3117. PubMed ID: 28940926
[TBL] [Abstract][Full Text] [Related]
6. A novel homozygous RIPK4 variant in a family with severe Bartsocas-Papas syndrome.
Dinçer T; Gümüş E; Toraman B; Er İ; Yildiz G; Yüksel Z; Kalay E
Am J Med Genet A; 2021 Jun; 185(6):1691-1699. PubMed ID: 33713555
[TBL] [Abstract][Full Text] [Related]
7. Receptor-interacting protein kinase 4 and interferon regulatory factor 6 function as a signaling axis to regulate keratinocyte differentiation.
Kwa MQ; Huynh J; Aw J; Zhang L; Nguyen T; Reynolds EC; Sweet MJ; Hamilton JA; Scholz GM
J Biol Chem; 2014 Nov; 289(45):31077-87. PubMed ID: 25246526
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte-Specific Ablation of RIPK4 Allows Epidermal Cornification but Impairs Skin Barrier Formation.
Urwyler-Rösselet C; Tanghe G; Leurs K; Gilbert B; De Rycke R; De Bruyne M; Lippens S; Bartunkova S; De Groote P; Niessen C; Haftek M; Vandenabeele P; Declercq W
J Invest Dermatol; 2018 Jun; 138(6):1268-1278. PubMed ID: 29317263
[TBL] [Abstract][Full Text] [Related]
9. Exome sequence identifies RIPK4 as the Bartsocas-Papas syndrome locus.
Mitchell K; O'Sullivan J; Missero C; Blair E; Richardson R; Anderson B; Antonini D; Murray JC; Shanske AL; Schutte BC; Romano RA; Sinha S; Bhaskar SS; Black GC; Dixon J; Dixon MJ
Am J Hum Genet; 2012 Jan; 90(1):69-75. PubMed ID: 22197488
[TBL] [Abstract][Full Text] [Related]
10. The RIPK4-IRF6 signalling axis safeguards epidermal differentiation and barrier function.
Oberbeck N; Pham VC; Webster JD; Reja R; Huang CS; Zhang Y; Roose-Girma M; Warming S; Li Q; Birnberg A; Wong W; Sandoval W; Kőműves LG; Yu K; Dugger DL; Maltzman A; Newton K; Dixit VM
Nature; 2019 Oct; 574(7777):249-253. PubMed ID: 31578523
[TBL] [Abstract][Full Text] [Related]
11. Expanding the genetic and phenotypic spectrum of popliteal pterygium disorders.
Leslie EJ; O'Sullivan J; Cunningham ML; Singh A; Goudy SL; Ababneh F; Alsubaie L; Ch'ng GS; van der Laar IM; Hoogeboom AJ; Dunnwald M; Kapoor S; Jiramongkolchai P; Standley J; Manak JR; Murray JC; Dixon MJ
Am J Med Genet A; 2015 Mar; 167A(3):545-52. PubMed ID: 25691407
[TBL] [Abstract][Full Text] [Related]
12. Disease-associated mutations in IRF6 and RIPK4 dysregulate their signalling functions.
Kwa MQ; Huynh J; Reynolds EC; Hamilton JA; Scholz GM
Cell Signal; 2015 Jul; 27(7):1509-16. PubMed ID: 25784454
[TBL] [Abstract][Full Text] [Related]
13. Exome analysis in clinical practice: expanding the phenotype of Bartsocas-Papas syndrome.
Gripp KW; Ennis S; Napoli J
Am J Med Genet A; 2013 May; 161A(5):1058-63. PubMed ID: 23610050
[TBL] [Abstract][Full Text] [Related]
14. RIPK4 regulates cell-cell adhesion in epidermal development and homeostasis.
Fortugno P; Monetta R; Belli M; Botti E; Angelucci F; Palmerini MG; Nottola SA; De Luca C; Ceccarini M; Salvatore M; Bianchi L; Macioce P; Teson M; Ricci F; ; Macchiarelli G; Didona B; Costanzo A; Castiglia D; Brancati F
Hum Mol Genet; 2022 Aug; 31(15):2535-2547. PubMed ID: 35220430
[TBL] [Abstract][Full Text] [Related]
15. RIPK4 activates an IRF6-mediated proinflammatory cytokine response in keratinocytes.
Kwa MQ; Scholz GM; Reynolds EC
Cytokine; 2016 Jul; 83():19-26. PubMed ID: 27014863
[TBL] [Abstract][Full Text] [Related]
16. RIPK4 suppresses the TGF-β1 signaling pathway in HaCaT cells.
Dinçer T; Boz Er AB; Er İ; Toraman B; Yildiz G; Kalay E
Cell Biol Int; 2020 Mar; 44(3):848-860. PubMed ID: 31825120
[TBL] [Abstract][Full Text] [Related]
17. A novel regulatory relationship between RIPK4 and ELF3 in keratinocytes.
Scholz GM; Sulaiman NS; Al Baiiaty S; Kwa MQ; Reynolds EC
Cell Signal; 2016 Dec; 28(12):1916-1922. PubMed ID: 27667567
[TBL] [Abstract][Full Text] [Related]
18. The NOTCH-RIPK4-IRF6-ELOVL4 Axis Suppresses Squamous Cell Carcinoma.
Yan Y; Gauthier MA; Malik A; Fotiadou I; Ostrovski M; Dervovic D; Ghadban L; Tsai R; Gish G; Loganathan SK; Schramek D
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765696
[TBL] [Abstract][Full Text] [Related]
19. Periderm: Life-cycle and function during orofacial and epidermal development.
Hammond NL; Dixon J; Dixon MJ
Semin Cell Dev Biol; 2019 Jul; 91():75-83. PubMed ID: 28803895
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines.
Xu L; Bajorski P; Poligone B
PLoS One; 2024; 19(4):e0287444. PubMed ID: 38630705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
